In 15 adults, zinc from citrate and gluconate was absorbed alike, about 61%, and from oxide less, about 50%.
Trial · 15 people · Single doses, 4 weeks apart · maker-funded
Wegmüller et al., Journal of Nutrition, 2014
Terms and sources
- 15 adults
- Healthy adults aged 18–45 at a university in Zurich. Each took all three forms in random order, one after the other, 4 weeks apart, without food.
- about 61%
- Medians: 61.3% from citrate, 60.9% from gluconate; they did not differ. 10 mg of zinc in a capsule, measured with zinc isotopes in urine.
- about 50%
- 49.9% from oxide; the difference from citrate and from gluconate was statistically significant. In two people, absorption from oxide was below the 1.5% detection limit; one absorbed 14%. Without the two, the overall difference was no longer statistically significant.
- maker-funded
- Funded by Jungbunzlauer International, Basel. Jungbunzlauer Ladenburg prepared the labeled zinc citrate and zinc gluconate. The authors declare no conflicts of interest.
Study · Free full text · about 14 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
This trial compared three zinc forms in 15 healthy adults aged 18–45. Each took 10 mg of zinc as citrate, gluconate and oxide, one at a time without food, 4 weeks apart. Absorption was measured with zinc isotopes in urine. About 61% was absorbed from citrate and from gluconate, and about 50% from oxide. In two people, absorption from oxide was below the detection limit. Without them, the difference was not statistically significant. Funding: Jungbunzlauer International. Jungbunzlauer Ladenburg prepared the labeled citrate and gluconate.
After one 15 mg dose in 12 women, the bisglycinate form gave 43% more zinc in blood than gluconate.
Trial · 12 people · Single doses, 7 days apart · industry author
Gandia et al., International Journal for Vitamin and Nutrition Research, 2007
Terms and sources
- 12 women
- Healthy female volunteers. Each took both forms in random order, one after the other, 7 days apart. The dose was two units of 7.5 mg.
- 43% more zinc in blood
- The abstract reports +43.4% oral bioavailability and calls it significant. It compared peak serum zinc and serum zinc over time. It does not say which measure gave 43.4%.
- industry author
- Two of seven authors list Laboratoire Oenobiol, Paris. Three list contract research firms. We could not check the funding section.
Study · Access not checked · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.
Study summary
This trial compared two zinc forms in 12 healthy women. Each took a single 15 mg dose of zinc as bisglycinate and as gluconate, in random order, 7 days apart. Blood zinc was measured over time. The authors report 43.4% higher oral bioavailability with bisglycinate, a statistically significant difference. The abstract does not say which blood measure gave this number. It calls bisglycinate a new formulation. Two of seven authors list Laboratoire Oenobiol, Paris. Funding: we could not check.
In 8 adults taking 2 mg zinc with milk, absorption was highest from aspartate, then gluconate, lowest from sulfate.
Trial · 8 people · Single doses, 2 weeks apart
Piacenza et al., Nutrients, 2023
Terms and sources
- 8 adults
- Healthy adults aged 25–50, 4 men and 4 women, with normal blood zinc. Each took all three forms in random order, one after the other, 2 weeks apart. The labeled zinc compounds came from Sigma-Aldrich.
- with milk
- Capsules with about 200 mL of cow's milk, in the morning, fasting.
- highest from aspartate
- Estimated absorption: aspartate 34.6%, gluconate 19.1%, sulfate 8.9%; the differences were statistically significant. The authors say these estimates serve comparison only, not absolute values.
Study · Free full text · about 14 min to read
Our estimate at about 200 words a minute, from the PMC full text.
Study summary
This small trial compared three zinc forms in 8 healthy adults aged 25–50. Each took 2 mg of zinc as aspartate, gluconate and sulfate with milk, in random order, 2 weeks apart. Absorption was estimated from a zinc isotope in urine after 48 hours. Estimates were 34.6% for aspartate, 19.1% for gluconate and 8.9% for sulfate, all statistically different. The authors call the study preliminary and the numbers comparative only. Funding: Regione Marche, an Italian regional government. The authors declare no conflicts of interest.
In 12 men, peak blood zinc was 18% higher with 20 mg as gluconate than 17.4 mg as oxide.
Trial · 12 people · 14 days each · industry author
Siepmann et al., International Journal of Clinical Pharmacology and Therapeutics, 2005
Terms and sources
- 12 men
- Healthy men aged 21–31. Each took both forms for 14 days in random order, one after the other, at least 14 days apart.
- 18% higher
- Peak blood zinc 18.3% higher; blood zinc over 24 hours 8.1% higher. Both differences were statistically significant.
- 20 mg
- 20 mg of zinc a day from gluconate and 17.4 mg from oxide, so the doses were not equal.
- industry author
- Author affiliations include Dr. Gerhard Mann Pharma, Berlin, and a contract research firm. We could not check the funding section.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract.
Study summary
This trial compared two zinc forms in 12 healthy men aged 21–31. Each took zinc gluconate and zinc oxide for 14 days each, in random order. The daily doses were 20 mg and 17.4 mg of zinc, so they were not equal. Peak blood zinc was 18.3% higher with gluconate, and the 24-hour total 8.1% higher. Both differences were statistically significant. Author affiliations include Dr. Gerhard Mann Pharma, Berlin. Funding: we could not check.
Adults aged 55–85 took 15 or 30 mg zinc daily; blood zinc rose, blood copper did not change.
Trial · 387 people · 6 months
Hininger-Favier et al., British Journal of Nutrition, 2007
Terms and sources
- Adults aged 55–85
- 387 healthy adults, living independently, aged 55–70 (188) and 70–85 (199), in France, Italy and Northern Ireland. Three groups: 15 mg, 30 mg or a dummy capsule, for 6 months. The ZENITH trial. Funded by the European Commission. E-Pharma (Creapharm, France) prepared and supplied the zinc gluconate.
- blood zinc rose
- Serum and urine zinc rose with both doses. Over the whole group, zinc in red blood cells did not change. It rose in the 70–85 group and in men. Urine zinc rose only in the 70–85 group and in women. The abstract says red cell SOD, a copper and zinc enzyme, did not change; the Results say it rose.
- 15 or 30 mg zinc daily
- At 30 mg, cholesterol, LDL and two iron markers rose at ages 55–70. Hemoglobin fell at 70–85. In women, hemoglobin fell, and iron markers and triglycerides rose. At 30 mg, the enzyme alkaline phosphatase rose at ages 55–70 and fell at 70–85.
- blood copper
- Serum copper, over the whole group. The Discussion adds that at 30 mg, serum copper fell in women.
Study · Access not checked · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.
Study summary
The ZENITH trial gave 387 healthy Europeans aged 55–85 zinc gluconate or a dummy capsule for 6 months. The zinc groups took 15 mg or 30 mg a day. Blood and urine zinc rose with both doses. Over the whole group, blood copper did not change. The abstract says red cell SOD did not change; the Results say it rose. At 30 mg, cholesterol and LDL rose at ages 55–70, and hemoglobin fell at 70–85. Funding: the European Commission. E-Pharma (Creapharm, France) prepared and supplied the zinc gluconate.
In 387 adults aged 55–87, 2 of 8 test scores differed with zinc, one in each direction.
Trial · 387 people · 6 months · funding not stated
Maylor et al., British Journal of Nutrition, 2006
Another report of the ZENITH trial above
Terms and sources
- 387 adults aged 55–87
- Healthy adults in France, Italy and Northern Ireland. 15 mg, 30 mg or a dummy capsule for 6 months. Computer tests of memory, attention and reaction time at the start, 3 and 6 months.
- one in each direction
- One spatial working memory score changed favorably with 15 or 30 mg, at 3 months only. One attention score changed unfavorably with 15 mg. Both were statistically significant. The other 6 did not differ.
- funding not stated
- We could not check this report's funding section. Hininger-Favier 2007, above, names the European Commission as the trial's funder.
Study · Access not checked · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.
Study summary
This report of the ZENITH trial tested memory, attention and reaction time in 387 healthy adults aged 55–87. They took 15 mg or 30 mg of zinc a day, or a dummy capsule, for 6 months. Of 8 test scores, 6 did not differ. One spatial working memory score changed favorably with both doses, at 3 months only. One attention score changed unfavorably with 15 mg. Funding: we could not check this report.
In 387 adults aged 55–87, positive and negative mood scores did not differ between zinc and a dummy capsule.
Trial · 387 people · 6 months · funding not stated
Stewart-Knox et al., Public Health Nutrition, 2011
Another report of the ZENITH trial above
Terms and sources
- 387 adults aged 55–87
- Healthy adults in Rome, Grenoble, Coleraine and Clermont-Ferrand. 15 mg or 30 mg of zinc gluconate a day, or a dummy capsule, for 6 months.
- mood scores
- Rated on a mood scale four times a day over 4 days, at the start, 3 and 6 months. Neither age group differed.
- funding not stated
- We could not check this report's funding section. Hininger-Favier 2007, above, names the European Commission as the trial's funder.
Study · Access not checked · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.
Study summary
This report of the ZENITH trial rated mood in 387 healthy adults aged 55–87. They took 15 mg or 30 mg of zinc gluconate a day, or a dummy capsule, for 6 months. Positive and negative mood were rated four times a day over 4 days, at the start, 3 and 6 months. Neither score differed between zinc and the dummy capsule, in either age group. Funding: we could not check this report.
In 38 men, 30 mg zinc daily for 14 weeks did not change copper markers versus a dummy product.
Trial · 38 people · 14 weeks · funding not stated
Bonham et al., Biological Trace Element Research, 2003
Terms and sources
- 38 men
- Healthy men; 19 took zinc and 19 a dummy product. Food gave about 10 mg of zinc a day, so total intake was about 40 mg.
- copper markers
- The authors call them putative indices of copper status. Blood fats and markers of blood clotting also did not change. After 14 weeks, the zinc group took 3 mg of copper a day for 8 weeks.
- funding not stated
- We could not check the funding section. PubMed lists an affiliation only for the first author, a diet and health research unit at the University of Ulster.
Study · Abstract only · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract.
Study summary
This trial gave 38 healthy men either 30 mg of zinc a day or a dummy product for 14 weeks. Their food gave about 10 mg of zinc a day, so total intake was about 40 mg. Markers the authors use for copper status did not change. Blood fats and blood clotting markers also did not change. Funding: not stated in the abstract.
In 44 women, 20 mg zinc daily for 2 months did not change iron absorption versus a dummy product.
Trial · 44 people · 2 months · funding not stated
López de Romaña et al., Nutrition, 2008
Terms and sources
- 44 women
- Healthy women aged 35–45 in Chile, assigned at random to zinc sulfate or a dummy product, taken between meals.
- iron absorption
- Measured with iron isotopes before and after 2 months. Iron status markers also did not differ. Plasma zinc did not change significantly in either group.
- funding not stated
- We could not check the funding section. PubMed lists an affiliation only for the first author, the Institute of Nutrition and Food Technology, University of Chile.
Study · Access not checked · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.
Study summary
This trial gave 44 healthy women in Chile, aged 35–45, zinc or a dummy product for 2 months. The zinc group took 20 mg of zinc as zinc sulfate between meals. Iron absorption was measured with iron isotopes before and after. It rose over time in both groups, with no difference between them. Iron status markers did not differ. Plasma zinc did not change significantly in either group. Funding: not stated in the abstract.
In 10 men, rated effort in an exercise test was lower with 20 mg zinc than with a dummy product.
Trial · 10 people · 7 days each · funding not stated
Khaled et al., Clinical Hemorheology and Microcirculation, 1999
Terms and sources
- 10 men
- Healthy men, average age 26. Each took zinc and a dummy product for 7 days, in random order, one after the other.
- rated effort
- A 25-minute test below maximal effort. Borg scale at minute 20: 5.6 with zinc and 6.6 with the dummy product; statistically significant. Blood viscosity at rest was also lower with zinc.
- funding not stated
- The abstract does not name who paid. PubMed lists an affiliation only for the first author, a hospital metabolism and muscle unit in Montpellier.
Study · Access not checked · about 2 min to read
Our estimate at about 200 words a minute, from the PubMed abstract. We could not check whether the full text is free.
Study summary
This small trial gave 10 healthy men 20 mg of zinc a day and a dummy product, 7 days each. The order was random. On day 8 they did a 25-minute exercise test below maximal effort. Rated effort at minute 20 was 5.6 with zinc and 6.6 with the dummy product, a statistically significant difference. Blood viscosity at rest was also lower with zinc. Funding: not stated in the abstract.